Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition

Published:2012 Issue:3-4 Volume:1 Page:247-256
ISSN:1664-5553
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Finn Richard S.

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA-binding protein QKI promotes the progression of HCC by interacting with long non-coding RNA EGOT;International Immunopharmacology;2024-07

2. Chemically engineered mTOR-nanoparticle blockers enhance antitumour efficacy;eBioMedicine;2024-05

3. Development of multi-drug resistance to anticancer drugs in HepG2 cells due to MRP2 upregulation on exposure to menthol;PLOS ONE;2023-09-21

4. Role of phospholipases in hepatocellular carcinoma;Phospholipases in Physiology and Pathology;2023

5. Potential Therapeutic Strategies to Combat HCC;Current Molecular Pharmacology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP